Impact of the COVID-19 pandemic on quality of life and mental health in children and adolescents in Germany.


Journal

European child & adolescent psychiatry
ISSN: 1435-165X
Titre abrégé: Eur Child Adolesc Psychiatry
Pays: Germany
ID NLM: 9212296

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 29 10 2020
accepted: 16 01 2021
pubmed: 26 1 2021
medline: 23 6 2022
entrez: 25 1 2021
Statut: ppublish

Résumé

The COVID-19 pandemic has caused unprecedented changes in the lives of 1.6 billion children and adolescents. First non-representative studies from China, India, Brazil, the US, Spain, Italy, and Germany pointed to a negative mental health impact. The current study is the first nationwide representative study to investigate the impact of the COVID-19 pandemic on health-related quality of life (HRQoL) and mental health of children and adolescents in Germany from the perspective of children themselves. A representative online survey was conducted among n = 1586 families with 7- to 17-year-old children and adolescents between May 26 and June 10. The survey included internationally established and validated instruments for measuring HRQoL (KIDSCREEN-10), mental health problems (SDQ), anxiety (SCARED), and depression (CES-DC). Results were compared with data from the nationwide, longitudinal, representative BELLA cohort study (n = 1556) conducted in Germany before the pandemic. Two-thirds of the children and adolescents reported being highly burdened by the COVID-19 pandemic. They experienced significantly lower HRQoL (40.2% vs. 15.3%), more mental health problems (17.8% vs. 9.9%) and higher anxiety levels (24.1% vs. 14.9%) than before the pandemic. Children with low socioeconomic status, migration background and limited living space were affected significantly more. Health promotion and prevention strategies need to be implemented to maintain children's and adolescents' mental health, improve their HRQoL, and mitigate the burden caused by COVID-19, particularly for children who are most at risk.

Identifiants

pubmed: 33492480
doi: 10.1007/s00787-021-01726-5
pii: 10.1007/s00787-021-01726-5
pmc: PMC7829493
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

879-889

Informations de copyright

© 2021. The Author(s).

Références

JAMA Pediatr. 2020 Oct 1;174(10):e202430
pubmed: 32492092
J Am Acad Child Adolesc Psychiatry. 1999 Oct;38(10):1230-6
pubmed: 10517055
Front Psychol. 2020 Nov 06;11:579038
pubmed: 33240167
Child Youth Serv Rev. 2017 Jan;72:71-81
pubmed: 28461713
J Affect Disord. 2020 Oct 1;275:112-118
pubmed: 32658812
Lancet Child Adolesc Health. 2020 Aug;4(8):634-640
pubmed: 32540024
Lancet Public Health. 2020 Jul;5(7):e371
pubmed: 32619538
Child Adolesc Psychiatry Ment Health. 2020 Jul 17;14:29
pubmed: 32695221
Child Adolesc Psychiatry Ment Health. 2020 May 12;14:20
pubmed: 32419840
Matern Child Health J. 2018 Aug;22(8):1093-1102
pubmed: 29744710
Eur Child Adolesc Psychiatry. 2015 Jun;24(6):651-63
pubmed: 25428179
Int J Environ Res Public Health. 2020 Aug 17;17(16):
pubmed: 32824594
Indian J Pediatr. 2020 Jul;87(7):532-536
pubmed: 32472347
Pediatrics. 2020 Oct;146(4):
pubmed: 32709738
Pediatr Emerg Med Pract. 2020 Jun 05;17(Suppl 6-1):1-27
pubmed: 32496723
Qual Life Res. 2014 Apr;23(3):791-803
pubmed: 23686556
Int J Environ Res Public Health. 2020 Aug 09;17(16):
pubmed: 32784898
Child Youth Serv Rev. 2020 Oct;117:105277
pubmed: 32834275
Eur Child Adolesc Psychiatry. 2008 Dec;17 Suppl 1:116-24
pubmed: 19132311
Lancet Glob Health. 2020 Jul;8(7):e861-e862
pubmed: 32405458
PLoS One. 2019 Mar 13;14(3):e0213700
pubmed: 30865713
J Child Psychol Psychiatry. 2015 Mar;56(3):345-65
pubmed: 25649325
J Pediatr. 2020 Jun;221:264-266.e1
pubmed: 32248989
Int J Environ Res Public Health. 2020 Oct 07;17(19):
pubmed: 33036461
J Fam Violence. 2010 Jan;25(1):53-63
pubmed: 20495613
Eur Child Adolesc Psychiatry. 2021 Oct;30(10):1559-1577
pubmed: 32918625
J Child Psychol Psychiatry. 1997 Jul;38(5):581-6
pubmed: 9255702
Br J Psychiatry. 2012 Apr;200(4):290-9
pubmed: 22403085
Int J Environ Res Public Health. 2020 Aug 27;17(17):
pubmed: 32867313
Eur J Public Health. 2001 Mar;11(1):4-10
pubmed: 11276570
J Health Monit. 2018 Mar 15;3(1):92-107
pubmed: 35586182
Clin Psychol Psychother. 2008 May-Jun;15(3):154-63
pubmed: 19115436
JAMA Pediatr. 2020 Sep 1;174(9):898-900
pubmed: 32329784
Eur Child Adolesc Psychiatry. 2020 Jun;29(6):749-758
pubmed: 32363492
JAMA Pediatr. 2020 Sep 01;174(9):868-873
pubmed: 32392288
Pediatrics. 2020 Oct;146(4):
pubmed: 32764151
Psychol Trauma. 2020 Aug;12(S1):S79-S81
pubmed: 32525382
Int J Public Health. 2009 Sep;54 Suppl 2:160-6
pubmed: 19652910
Confl Health. 2020 Oct 02;14:67
pubmed: 33024451
Z Kinder Jugendpsychiatr Psychother. 2002 May;30(2):105-12
pubmed: 12053874
JAMA Pediatr. 2020 Sep 01;174(9):882-889
pubmed: 32320004

Auteurs

Ulrike Ravens-Sieberer (U)

Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. ravens-sieberer@uke.de.

Anne Kaman (A)

Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Michael Erhart (M)

Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Alice Salomon University of Applied Science, Berlin, Germany.
Apollon University of Applied Science of Healthcare Economy, Bremen, Germany.

Janine Devine (J)

Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Argora Clinic, Psychosomatic Clinic and Outpatient Center, Berlin, Germany.

Robert Schlack (R)

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Christiane Otto (C)

Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH